{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:18:49Z","timestamp":1648786729834},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1007\/bf02988654","type":"journal-article","created":{"date-parts":[[2008,11,15]],"date-time":"2008-11-15T12:25:34Z","timestamp":1226751934000},"page":"511-514","source":"Crossref","is-referenced-by-count":1,"title":["Prediction of therapy response to interferon-alpha in chronic viral hepatitis-B by liver and hepatobiliary scintigraphy"],"prefix":"10.1007","volume":"16","author":[{"given":"Meltem","family":"Caglar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oktay","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Akcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02988654_CR1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","volume":"321","author":"GL Davis","year":"1989","unstructured":"Davis GL, Balart LA, Schiff ER, et al. Hepatitis Intervertional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial.N Eng J Med 1989; 321: 1501\u20131506.","journal-title":"N Eng J Med"},{"key":"BF02988654_CR2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","volume":"321","author":"AM Bisceglie Di","year":"1989","unstructured":"Di Bisceglie AM, Martin P, Kassiandes C, et al. Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.N Eng J Med 1989; 321: 1506\u20131510.","journal-title":"N Eng J Med"},{"key":"BF02988654_CR3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/hep.1840130302","volume":"13","author":"P Marcellin","year":"1991","unstructured":"Marcellin P, Boyer N, Giostra E, et al. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.Hepatology 1991; 13: 393\u2013397.","journal-title":"Hepatology"},{"key":"BF02988654_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0676.1995.tb00108.x","volume":"15","author":"K Yoshioka","year":"1995","unstructured":"Yoshioka K, Higashi YK, Yamada M, et al. Predictive factors in the response to interferon therapy in chronic hepatitis C.Liver 1995; 15: 57\u201362.","journal-title":"Liver"},{"key":"BF02988654_CR5","first-page":"154","volume":"87","author":"M Soresi","year":"1996","unstructured":"Soresi M, Tripi S, Cartabellota A, et al. Factors predicting the response to alpha-interferon therapy in patients with chronic hepatitis C.Recenti Prog Med 1996; 87: 154\u2013157.","journal-title":"Recenti Prog Med"},{"key":"BF02988654_CR6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC, et al. Formation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.Hepatology 1981; 1: 431\u2013435.","journal-title":"Hepatology"},{"key":"BF02988654_CR7","first-page":"97","volume-title":"Viral Hepatitis and Liver Disease","author":"JH Hoofnagle","year":"1984","unstructured":"Hoofnagle JH, Alter HJ. Chronic viral hepatitis. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds.Viral Hepatitis and Liver Disease. New York: Grune Stratton, 1984: 97\u2013113."},{"key":"BF02988654_CR8","first-page":"619","volume":"88","author":"B Mullhaupt","year":"1999","unstructured":"Mullhaupt B, Renner EL. Therapy of chronic hepatitis B and C.Schweiz Rundsch Med Prax 1999; 88: 619\u2013632.","journal-title":"Schweiz Rundsch Med Prax"},{"key":"BF02988654_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(96)80022-5","volume":"24","author":"G Mazzela","year":"1996","unstructured":"Mazzela G, Accogli E, Sottili S, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.J Hepatol 1996; 24: 141\u2013147.","journal-title":"J Hepatol"},{"key":"BF02988654_CR10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7326\/0003-4819-115-9-700","volume":"115","author":"M Shindo","year":"1991","unstructured":"Shindo M, Di Bisceglie AM, Cheung L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.Ann Intern Med 1991; 115: 700\u2013704.","journal-title":"Ann Intern Med"},{"key":"BF02988654_CR11","first-page":"804","volume":"25","author":"K Hasegawa","year":"1994","unstructured":"Hasegawa K, Hasegawa M, Kusakabe K, et al. Evaluation of usefulness of Tc-99m GSA scintigraphy in patients with hepatitis C treated with alpha interferon.Nippon Igaku Hoshasen Gakkai Zasshi 1994; 25: 804\u2013806.","journal-title":"Nippon Igaku Hoshasen Gakkai Zasshi"},{"key":"BF02988654_CR12","first-page":"888","volume":"42","author":"DH Thiel Van","year":"1995","unstructured":"Van Thiel DH, Friedlander L, Malloy P, et al. Gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C.Hepatogastroenterology 1995; 42: 888\u2013892.","journal-title":"Hepatogastroenterology"},{"key":"BF02988654_CR13","first-page":"177","volume-title":"Essentials of Nuclear Medicine Imaging","year":"1991","unstructured":"Mettler FA, Guiberteau MJ (eds).Essentials of Nuclear Medicine Imaging. Philadelphia, WB Saunders Company, 1991: 177\u2013207."},{"key":"BF02988654_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.41.1.115","volume":"41","author":"E Boucher","year":"1997","unstructured":"Boucher E, Bourienne A, Adams P, et al. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment.Gut 1997; 41: 115\u2013120.","journal-title":"Gut"},{"key":"BF02988654_CR15","first-page":"523","volume":"89","author":"R Martin-Vivaldi","year":"1997","unstructured":"Martin-Vivaldi R, Nogueras F, Gonzales A, et al. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.Rev Esp Enferm Dig 1997; 89: 523\u2013530.","journal-title":"Rev Esp Enferm Dig"},{"key":"BF02988654_CR16","first-page":"54","volume":"8","author":"AR Reizis","year":"1990","unstructured":"Reizis AR, Nikitina TS, Shalygina NB, et al. Functional metabolic activity of the mononuclear phagocyte system of the blood, liver, spleen and skin in children with hepatitis B.Pediatriia 1990; 8: 54\u201359.","journal-title":"Pediatriia"},{"key":"BF02988654_CR17","first-page":"310","volume":"20","author":"E Harvey","year":"1979","unstructured":"Harvey E, Loberg M, Ryan J. Hepatic clearance mechanism of Tc-99m HIDA and its effect on quantitation of hepatobiliary biliary function: concise communication.J Nucl Med 1979; 20: 310\u2013313.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02988654\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:56:12Z","timestamp":1558569372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02988654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["BF02988654"],"URL":"https:\/\/doi.org\/10.1007\/bf02988654","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}